Martin Gallagher

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine

Steven D. Weisbord, Martin Gallagher, Hani Jneid et al. · New England Journal of Medicine · 2017 · 487 citations · Full text

Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey

Nicole Evangelidis, Allison Tong, Braden Manns et al. · American Journal of Kidney Diseases · 2017 · 289 citations · Full text

Hemodialysis, Health Policy, Medicine +11

Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jennifer E. Flythe, Tara I. Chang, Martin Gallagher et al. · Kidney International · 2020 · 240 citations · Full text

Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation

Martin Gallagher, Patrick J. Kelly, Meg Jardine et al. · Journal of the American Society of Nephrology · 2010 · 213 citations

Cancer Management, Functioning Transplant, Dermatology +17